This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Sadasiva Rao Ginjupalli: Innovator in Pharmaceutical Chemistry
Introduction
Sadasiva Rao Ginjupalli is a notable inventor based in Guntur, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds used in medical applications. His work has led to the development of innovative processes that enhance the efficiency of drug production.
Latest Patents
Sadasiva Rao Ginjupalli holds a patent for "Processes for preparation of Sugammadex and intermediates thereof." This invention relates to a process for the preparation of 6-perdeoxy-6-per-chloro gamma-cyclodextrin, which is a key intermediate useful in the synthesis of Sugammadex sodium. The patent also details a process for the preparation and purification of Sugammadex sodium, showcasing his expertise in creating valuable pharmaceutical compounds.
Career Highlights
Throughout his career, Ginjupalli has demonstrated a commitment to advancing pharmaceutical science. His innovative approaches have not only contributed to the field but have also paved the way for further research and development in drug synthesis. His patent reflects his dedication to improving medical treatments through scientific innovation.
Collaborations
Sadasiva Rao Ginjupalli has collaborated with notable colleagues, including Lakshmi Prasad Alaparthi and Talluri Bhushaiah Chowdary. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the pharmaceutical industry.
Conclusion
Sadasiva Rao Ginjupalli is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug synthesis. His patent for the preparation of Sugammadex sodium exemplifies his innovative spirit and dedication to improving healthcare solutions. His contributions continue to inspire future research and development in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile